The 23,000 SF facility will focus on gene therapy CDMO process development and have Good Manufacturing Practice (GMP) manufacturing capabilities. The areas in this facility will include Process and Analytical Development Labs, GMP Manufacturing Clean Rooms and Supporting Areas, QC Labs, Warehouse, Office Space, New Storage Mezzanine above Warehouse and a New Office Mezzanine.